| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 5497717 | Applied Radiation and Isotopes | 2017 | 7 Pages |
Abstract
The alpha particle emitter Radium-223 dichloride (223RaCl2) has recently been approved for treatment of late-stage bone metastatic prostate cancer. There is considerable interest in studying this new agent outside of the clinical setting, however the supply of 223Ra is limited and expensive. We have engineered a 223Ra microgenerator using traces of 227Ac previously generated from cyclotron-produced 225Ac. Radiochemically pure 223RaCl2 was made, characterized, evaluated in vivo, and the source was recovered in high yield for regeneration of the microgenerator.
Related Topics
Physical Sciences and Engineering
Physics and Astronomy
Radiation
Authors
Diane S. Abou, Juile Pickett, John E. Mattson, Daniel L.J. Thorek,